Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis

14Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Cystic fibros.000000 bacterial pulmonary infections and neutrophil-dominated inflammation in the airways. The aim of this study was to evaluate the neutrophil-derived protein Heparin-binding protein (HBP) as a potential sputum marker of airway inflammation and bacterial load. Methods: Nineteen CF patients, aged 6-18 years, were prospectively followed for 6 months with sputum sampling at every visit to the CF clinic. A total of 41 sputum samples were collected. Sputum-HBP was analysed with ELISA, neutrophil elastase activity with a chromogenic assay, and total bacterial load with RT-PCR of the 16 s rDNA gene. Data were compared to lung function parameters and airway symptoms. Results: HBP and elastase correlated to a decrease in FEV 1 %predicted compared to the patients' individual baseline pulmonary function (ΔFEV 1 ), but not to bacterial load. Area under the receiver operating characteristic curve values for the detection of > 10% decrease in ΔFEV 1 were 0.80 for HBP, 0.78 for elastase, and 0.54 for bacterial load. Conclusions: Sputum HBP is a promising marker of airway inflammation and pulmonary function in children with CF.

Cite

CITATION STYLE

APA

Hovold, G., Palmcrantz, V., Kahn, F., Egesten, A., & Påhlman, L. I. (2018). Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis. BMC Pulmonary Medicine, 18(1). https://doi.org/10.1186/s12890-018-0668-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free